Yamazaki, H., Suzuki, G., Masui, K., Aibe, N., Shimizu, D., Kimoto, T., . . . Okabe, H. (2021). Radiotherapy for Clinically Localized T3b or T4 Very-High-Risk Prostate Cancer-Role of Dose Escalation Using High-Dose-Rate Brachytherapy Boost or High Dose Intensity Modulated Radiotherapy. Cancers (Basel).

Yamazaki, Hideya, Gen Suzuki, Koji Masui, Norihiro Aibe, Daisuke Shimizu, Takuya Kimoto, Ken Yoshida, Satoaki Nakamura, et Haruumi Okabe. "Radiotherapy for Clinically Localized T3b or T4 Very-High-Risk Prostate Cancer-Role of Dose Escalation Using High-Dose-Rate Brachytherapy Boost or High Dose Intensity Modulated Radiotherapy." Cancers (Basel) 2021.

Yamazaki, Hideya, et al. "Radiotherapy for Clinically Localized T3b or T4 Very-High-Risk Prostate Cancer-Role of Dose Escalation Using High-Dose-Rate Brachytherapy Boost or High Dose Intensity Modulated Radiotherapy." Cancers (Basel) 2021.